ストックスクリーナーアプリを入手
2.30
0.65%
-0.015
前日終値:
$2.315
開ける：
$2.29
24時間の取引高:
101.44K
Relative Volume:
0.23
時価総額：
$47.38M
収益：
-
当期純損益:
$-16.51M
株価収益率:
-1.2568
EPS:
-1.83
ネットキャッシュフロー:
$-15.68M
1週間 パフォーマンス:
-9.80%
1か月 パフォーマンス:
+18.56%
6か月 パフォーマンス:
-41.92%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.2409
$2.3599
1週間の範囲:
$2.235
$2.6999
52週間の値動き範囲:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
名前
Medicus Pharma Ltd
セクター
電話
610-540-7515
住所
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
MDCX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.2409 | 47.38M | 0 | -16.51M | -15.68M | -1.83 |
|
LLY
Lilly Eli Co
|
802.50 | 684.00B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
185.00 | 446.55B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
238.18 | 409.03B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
130.12 | 248.25B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
87.72 | 209.64B | 63.43B | 16.42B | 14.72B | 6.49 |
Medicus Pharma Ltd (MDCX) 最新ニュース
Is Medicus Pharma Ltd. Equity Warrant still worth holding after the dipJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Smart tools for monitoring Medicus Pharma Ltd. Equity Warrant’s price actionJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Why Medicus Pharma Ltd. (N460) stock fits value portfoliosJuly 2025 Pullbacks & Entry Point Strategy Guides - newser.com
Using data filters to optimize entry into Medicus Pharma Ltd.Market Performance Summary & Technical Confirmation Trade Alerts - newser.com
Custom strategy builders for tracking Medicus Pharma Ltd. Equity Warrant2025 Big Picture & Low Risk Entry Point Tips - newser.com
Medicus Pharma Ltd’s Promising Prospects: Innovative BCC Treatment and Strong FDA Support Drive Buy Rating - TipRanks
Relative strength of Medicus Pharma Ltd. Equity Warrant in sector analysis2025 Momentum Check & Daily Price Action Insights - newser.com
Trend analysis for Medicus Pharma Ltd. Equity Warrant this week2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Using AI based signals to follow Medicus Pharma Ltd. Equity WarrantRecession Risk & Weekly Chart Analysis and Guides - newser.com
How currency fluctuations impact Medicus Pharma Ltd. Equity Warrant stockPrice Action & Reliable Entry Point Trade Alerts - newser.com
Medicus Pharma gets FDA nod for 505(b)(2) pathway in skin cancer treatment - Investing.com Nigeria
What Wall Street predicts for Medicus Pharma Ltd. stock priceStop Loss & Long-Term Growth Stock Strategies - newser.com
How Medicus Pharma Ltd. (N460) stock performs in easing cyclesEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Naples Daily News
Is Medicus Pharma Ltd. Equity Warrant stock entering bullish territory2025 Short Interest & Verified Short-Term Trading Plans - newser.com
Medicus Pharma gets positive FDA feedback on Skinject microneedle therapy for basal cell carcinoma - Proactive financial news
Is Medicus Pharma Ltd. Equity Warrant stock affected by interest rate hikesAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
How Medicus Pharma Ltd. (N460) stock reacts to Fed tighteningQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Medicus Pharma Ltd. Equity Warrant stock outlook for YEAREarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Medicus Pharma Advances Skinject Development with Positive FDA Feedback - TipRanks
Medicus Pharma gets FDA backing to advance skin cancer patch - Proactive financial news
Medicus Pharma announces feedback from FDA Type C Meeting for Skinject - TipRanks
$2B Market Opportunity: Medicus's Non-Invasive Skin Cancer Treatment Gets FDA Development Green Light - Stock Titan
Is Medicus Pharma Ltd. (N460) stock a momentum leader2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Regression analysis insights on Medicus Pharma Ltd. performanceGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Can Tirupati Sarjan Limited Expand Its Margins in a HighRate EnvironmentIndustrial Stocks Review & You’ll Regret Not Buying These Early - earlytimes.in
Is Medicus Pharma Ltd Equity Warrant a good long term investmentDividend Stock Watch & Free Superior Trading Gains - earlytimes.in
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - Online Athens
Medicus Pharma Ltd Equity Warrant Stock Analysis and ForecastMarket Sentiment Shifts & Small Entry Portfolio - earlytimes.in
How Medicus Pharma Ltd. (N460) stock trades in high volatility2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
Is Medicus Pharma Ltd. Equity Warrant forming a bottoming baseWeekly Profit Analysis & Technical Pattern Recognition Alerts - newser.com
Medicus Pharma to Present Key Developments at Brookline Capital Markets - MSN
Custom strategy builders for tracking Medicus Pharma Ltd.Weekly Trend Report & AI Forecasted Stock Moves - newser.com
Stonegate Capital Partners Initiates Coverage on Medicus Pharma with $21.13 Valuation Target - citybuzz -
Medicus Pharma price target raised to $20 from $12 at Brookline - TipRanks
Medicus Pharma receives coverage from Stonegate Capital Partners - Proactive financial news
Stonegate Capital Partners Initiates Coverage on Medicus Pharma Ltd. (MDCX) - StreetInsider
Medicus Pharma to present at Brookline Capital Markets - Proactive financial news
Medicus Pharma Ltd. To Present at Brookline Capital Markets - ACCESS Newswire
Medicus Pharma announces $8M debenture financing - MSN
Technical Analysis: Can Medicus Pharma Ltd expand its profit marginsJuly 2025 Short Interest & Safe Entry Momentum Tips - khodrobank.com
Medicus Pharma closes Antev acquisition, expands skin cancer trialICYMI - Proactive financial news
Setup Watch: Is Meihua International Medical Technologies Co Ltd in a long term uptrend2025 Price Momentum & High Accuracy Investment Signals - khodrobank.com
Is Medicus Pharma Ltd stock a good pick for beginners2025 Winners & Losers & Fast Moving Trade Plans - خودرو بانک
Analysis Recap: Can Medicus Pharma Ltd Equity Warrant disrupt its industryProduct Launch & AI Based Buy and Sell Signals - خودرو بانک
Is Medicus Pharma Ltd. showing signs of accumulationProduct Launch & High Return Stock Watch Alerts - newser.com
Trading Recap: Is Medicus Pharma Ltd stock heavily shortedShare Buyback & Community Consensus Picks - khodrobank.com
Weekly Earnings: How sensitive is Medicus Pharma Ltd. Equity Warrant to inflationPortfolio Value Summary & Risk Controlled Stock Alerts - خودرو بانک
Can Syndax Pharmaceuticals Inc stock double in the next yearMarket Rally & AI Forecasted Entry and Exit Points - khodrobank.com
Retail Surge: Is Medicus Pharma Ltd stock a good pick for beginners2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - خودرو بانک
Medicus Pharma Ltd (MDCX) 財務データ
収益
当期純利益
現金流量
EPS
4.82%
大文字化:
|
ボリューム (24 時間):